Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James L Kennedy

Showing results (1-10 of 543) with videos related to

Pageof 55
Sort By:
Pharmacogenomics|July 18, 2013
Incorporating psychiatric pharmacogenetics into family practiceJames L Kennedy, Nicholas C Voudouris
Pharmacogenomics|September 20, 2006
Genetics of antipsychotic treatment emergent weight gain in schizophreniaDaniel J Müller, James L Kennedy
Behavioural Brain Research|February 28, 2002
A transmission disequilibrium test of the Ser9/Gly dopamine D3 receptor gene polymorphism in adult attention-deficit hyperactivity disorderPierandrea Muglia, Umesh Jain, James L Kennedy
Addiction (Abingdon, England)|August 19, 2009
Genetic aspects of pathological gambling: a complex disorder with shared genetic vulnerabilitiesDaniela S S Lobo, James L Kennedy
CNS Spectrums|December 6, 2006
The genetics of gambling and behavioral addictionsDaniela S S Lobo, James L Kennedy
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 18, 2007
Power based association analysis (PBAT) of serotonergic and noradrenergic polymorphisms in bipolar patients with suicidal behaviourVincenzo De Luca, John Strauss, James L Kennedy
International Review of Psychiatry (Abingdon, England)|October 25, 2013
Future roles of pharmacogenomic testing and biomarkers in psychiatryDaniel J Mueller, James L Kennedy, Hubertus Himmerich
Psychiatry and Clinical Neurosciences|May 3, 2019
The coming-of-age of pharmacogenetic testing in clinical psychiatryKazunari Yoshida, Daniel J Müller, James L Kennedy
Current Psychiatry Reports|February 22, 2011
Genetics of antipsychotic-induced side effects and agranulocytosisNabilah I Chowdhury, Gary Remington, James L Kennedy
European Psychiatry : the Journal of the Association of European Psychiatrists|May 29, 2007
Association study between the corticotropin-releasing hormone receptor 2 gene and suicidality in bipolar disorderVincenzo De Luca, Subi Tharmalingam, James L Kennedy
Pageof 55

Showing results (1-10 of 543) with videos related to

Sort By:
Pageof 55
Pharmacogenomics|July 18, 2013
Incorporating psychiatric pharmacogenetics into family practiceJames L Kennedy, Nicholas C Voudouris
Pharmacogenomics|September 20, 2006
Genetics of antipsychotic treatment emergent weight gain in schizophreniaDaniel J Müller, James L Kennedy
Behavioural Brain Research|February 28, 2002
A transmission disequilibrium test of the Ser9/Gly dopamine D3 receptor gene polymorphism in adult attention-deficit hyperactivity disorderPierandrea Muglia, Umesh Jain, James L Kennedy
Addiction (Abingdon, England)|August 19, 2009
Genetic aspects of pathological gambling: a complex disorder with shared genetic vulnerabilitiesDaniela S S Lobo, James L Kennedy
CNS Spectrums|December 6, 2006
The genetics of gambling and behavioral addictionsDaniela S S Lobo, James L Kennedy
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 18, 2007
Power based association analysis (PBAT) of serotonergic and noradrenergic polymorphisms in bipolar patients with suicidal behaviourVincenzo De Luca, John Strauss, James L Kennedy
International Review of Psychiatry (Abingdon, England)|October 25, 2013
Future roles of pharmacogenomic testing and biomarkers in psychiatryDaniel J Mueller, James L Kennedy, Hubertus Himmerich
Psychiatry and Clinical Neurosciences|May 3, 2019
The coming-of-age of pharmacogenetic testing in clinical psychiatryKazunari Yoshida, Daniel J Müller, James L Kennedy
Current Psychiatry Reports|February 22, 2011
Genetics of antipsychotic-induced side effects and agranulocytosisNabilah I Chowdhury, Gary Remington, James L Kennedy
European Psychiatry : the Journal of the Association of European Psychiatrists|May 29, 2007
Association study between the corticotropin-releasing hormone receptor 2 gene and suicidality in bipolar disorderVincenzo De Luca, Subi Tharmalingam, James L Kennedy
Pageof 55